HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akiko Hiramoto Selected Research

Floxuridine (FUdR)

11/2020Intracellular microRNA expression patterns influence cell death fates for both necrosis and apoptosis.
8/2020Anticancer Strategy Targeting Cell Death Regulators: Switching the Mechanism of Anticancer Floxuridine-Induced Cell Death from Necrosis to Apoptosis.
1/2020Direct interaction analysis of microRNA-351-5p and nuclear scaffold lamin B1 mRNA by the cell-free in vitro mRNA/miRNA binding evaluation system.
1/2016MicroRNA-351 Regulates Two-Types of Cell Death, Necrosis and Apoptosis, Induced by 5-fluoro-2'-deoxyuridine.
4/2014Role of activating transcription factor 3 protein ATF3 in necrosis and apoptosis induced by 5-fluoro-2'-deoxyuridine.
5/2010Protein expression profiles of necrosis and apoptosis induced by 5-fluoro-2'-deoxyuridine in mouse cancer cells.
1/2009Association of nuclear-intermediate filament lamin B1 with necrotic- and apoptotic-morphologies in cell death induced by 5-fluoro-2'-deoxyuridine.
7/2008Gene expression profiles of necrosis and apoptosis induced by 5-fluoro-2'-deoxyuridine.
5/2008Association of nuclear membrane protein lamin B1 with necrosis and apoptosis in cell death induced by 5-fluoro-2'-deoxyuridine.
1/2008Molecular mechanisms in two cell death-types, necrosis and apoptosis, induced by 5-fluoro-2'-deoxyuridine.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akiko Hiramoto Research Topics

Disease

14Neoplasms (Cancer)
01/2020 - 01/2006
12Necrosis
11/2020 - 01/2006
6Malaria
10/2019 - 09/2011
1Carcinoma (Carcinomatosis)
08/2020
1Chronic Hepatitis C
10/2013
1Schistosomiasis (Bilharziasis)
09/2011
1Virus Diseases (Viral Diseases)
11/2010

Drug/Important Bio-Agent (IBA)

12Floxuridine (FUdR)FDA LinkGeneric
11/2020 - 01/2006
75-fluoro-2'-deoxyuridineIBA
01/2016 - 01/2008
7Proteins (Proteins, Gene)FDA Link
04/2014 - 01/2008
6Pharmaceutical PreparationsIBA
08/2020 - 07/2008
4Antimalarials (Antimalarial Agents)IBA
10/2019 - 12/2011
3MicroRNAs (MicroRNA)IBA
11/2020 - 01/2016
2Antineoplastic Agents (Antineoplastics)IBA
11/2020 - 05/2010
2Lamin Type B (Lamin B)IBA
01/2020 - 05/2008
21- (3- C- ethynylribopentofuranosyl)cytosineIBA
01/2017 - 01/2009
2RNA Polymerase I (Polymerase I, RNA)IBA
01/2017 - 11/2010
2artemisinin (artemisinine)IBA
02/2015 - 12/2012
2ProteomeIBA
01/2007 - 01/2006
1geldanamycinIBA
11/2020
1Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2020
1Messenger RNA (mRNA)IBA
01/2017
1Uridine KinaseIBA
01/2017
1Activating Transcription Factor 3IBA
04/2014
1InterferonsIBA
10/2013
1Ribavirin (Virazole)FDA LinkGeneric
10/2013
1nonadecaneIBA
09/2011
1EndoribonucleasesIBA
11/2010
1Apoptosis Regulatory ProteinsIBA
11/2010
12-5A-dependent ribonuclease (RNase L)IBA
11/2010
1ras ProteinsIBA
11/2010
1Ribonucleases (Ribonuclease)IBA
11/2010
1Keratin-19 (Keratin 19)IBA
05/2010
1CytosineIBA
04/2009
1Biological ProductsIBA
07/2008
1Complementary DNA (cDNA)IBA
07/2008
1DeoxyuridineIBA
05/2008

Therapy/Procedure

3Therapeutics
02/2015 - 12/2012
1Drug Therapy (Chemotherapy)
01/2009